Navigation Links
Canadian synchrotron conference sheds light on new biomedical research
Date:6/15/2009

Science fact surpasses science fiction at the Canadian Light Source (CLS) synchrotron's 12th Annual Users' Meeting Thursday, June 18 at the Radisson Hotel in Saskatoon. Conference participants will hear about some of the newest biomedical results from the CLS, as well as ways that synchrotron techniques are lighting the way to advances in environmental clean up and nanotechnology.

Highlights include:

  • Presentations by CLS users on using the synchrotron to study esophageal tumours, prion diseases such as BSE, watch nerves regenerate and treat tuberculosis
  • Applications of synchrotron techniques to agricultural research, developing bioproducts and bioremediation
  • Studying nanomaterials and materials at extreme conditions

Science fact is preceded by a free public lecture "Science Fiction as a Mirror for Reality" by internationally renowned science fiction author and CLS writer-in-residence Robert J. Sawyer on Wednesday, June 17 at 7 pm at the Frances Morrison Library Theatre.


'/>"/>

Contact: Matthew Dalzell
matt.dalzell@lightsource.ca
306-657-3739
Canadian Light Source, Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. University of Saskatchewan and Canadian Synchrotron researchers shed light on esophageal disease
2. Canadian-based UN coral reef expert honored at world meeting in Australia
3. Canadian biomedical engineering pioneer receives international award
4. Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic
5. Canadian scientist mines drugs database for new diabetes treatment
6. First images from medical beamline at Canadian Light Source
7. Massive Canadian oilfield could be exploited using new UK system
8. Canadian Society of Exercise Physiology Annual Scientific Conference
9. Ancient organisms discovered in Canadian gold mine
10. First Science from the Compact Light Source: A miniature synchrotron for your home lab
11. Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... Jan. 5, 2017  Delta ID Inc., a leader ... technology for automotive at CES® 2017. Delta ID has ... to demonstrate the use of iris scanning as a ... the driver in a car, and as a way ... experience. Delta ID and Gentex will demonstrate ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Basel, Switzerland (PRWEB) , ... ... ... leading provider of advanced software solutions for pharmaceutical research and development (R&D), ... project-based expertise in omic data analysis and interpretation for the rapidly evolving ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... ... National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the ... element of grant applications subject to the existing policy. AMIA recommended that NIH ...
(Date:1/19/2017)... -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. ... and inoperable solid tumor cancers, announced today that Dr. ... Bio, will present at the Phacilitate Immunotherapy World Conference ... Hotel in Miami, Florida . ... Therapeutic Approaches – Expanding the Reach of Cancer Immunotherapy ...
(Date:1/18/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, will feature data from two clinical ... 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, ... Napabucasin is an orally-administered investigational agent designed to ... Cancer stem cells (CSCs) possess the property of stemness ...
Breaking Biology Technology: